Sales and Marketing

Showing 15 posts of 11524 posts found.

MHRA accepts Roche’s Tecentriq into Early Access to Medicines scheme

January 25, 2017 Research and Development, Sales and Marketing MHRA, Roche, eams, tecentriq

Roche’s Tecentriq (atezolizumab) has scored another positive opinion, this time from the Medicines and Healthcare products Regulatory Agency (MHRA), which …
roche_close

Roche’s Actemra granted Priority Review by FDA

January 24, 2017 Manufacturing and Production, Sales and Marketing Actemra, FDA, Roche, priority review

Roche’s drug, Actemra (also known as RoActemra in Europe), has been granted priority review designation by the FDA for the …
computer_doctor

Thinking big data

January 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, IBM Watson Health, ibm

The potential solutions offered by ‘big data’ seems to offer a vision of the future but potential solutions aren’t enough …
kaleo

Rival to EpiPen to be made available to many for free

January 23, 2017 Manufacturing and Production, Sales and Marketing Kaleo, Mylan, epipen, rival

Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …
vaccination-1215279_960_720

CEPI backed by Bill Gates raises funds to combat epidemics

January 23, 2017 Medical Communications, Sales and Marketing Bill & Melinda Gates foundation, Bill Gates, CEPI

CEPI, the Coalition for Epidemic Preparedness Innovations, have launched the beginning of its fundraising initiative – with the aim of …
treasure_map

Leaflets offering gold coins for paediatricians appear at Bengaluru event

January 23, 2017 Medical Communications, Sales and Marketing India, PEDICON

Pharmaceutical firms in India are not allowed to offer any kind of reimbursement for privileging certain treatment over others, this …

Artificial skin development has implications for clinical trials

January 23, 2017 Medical Communications, Sales and Marketing Seoul National University Hospital, artificial skin, dermatology

Researchers from Seoul National University Hospital have announced that it has developed a microchip that has been designed to replicate …

BMS receives $625 million patent settlement boost from Merck

January 23, 2017 Sales and Marketing BMS, MSD, Merck, keytruda, opdivo

Bristol-Myers Squibb were in desperate need of releasing good news after the brief announcement that it would no longer be …
mallinckrodt-project

Company in 85,000% infant epilepsy drug price increase receives $100 million fine

January 23, 2017 Sales and Marketing Mallinckrodt, Martin Skhreli

Mallinckrodt Pharmaceuticals has hit the headlines for particularly dispiriting reasons – with further evidence of practise by some companies that …

J&J’s Imbruvica scores fifth FDA lymphoma approval

January 20, 2017 Medical Communications, Research and Development, Sales and Marketing FDA, Marginal Zone Lymphoma, imbruvica

Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday, and there have been some big revelations for the pharma industry this week. Brexit, the ever-present hot topic …
jenny_tragner_-_main

Pharmaceutical R&D tax credit regulatory legislation: The need for clarity

January 20, 2017 Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile

Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech …

Sanofi diabetes drug Sulinqua green-lighted in Europe

January 19, 2017 Research and Development, Sales and Marketing Sanofi, Sulinqua

Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission, giving the go ahead for the launch …
bi_german_building_at_night

Boehringer steps into Humira race with US and EU biosimilar filings

January 19, 2017 Sales and Marketing Boehringer Ingelheim, Humira, biosimilar

Boehringer Ingelheim has just stepped into the ring to battle it out for a slice of Humira’s revenue with accepted …
The Gateway to Local Adoption Series

Latest content